227 related articles for article (PubMed ID: 36011027)
1. STEAP1-4 (Six-Transmembrane Epithelial Antigen of the Prostate 1-4) and Their Clinical Implications for Prostate Cancer.
Xu M; Evans L; Bizzaro CL; Quaglia F; Verrillo CE; Li L; Stieglmaier J; Schiewer MJ; Languino LR; Kelly WK
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011027
[TBL] [Abstract][Full Text] [Related]
2. Cryo-electron microscopy structure and potential enzymatic function of human six-transmembrane epithelial antigen of the prostate 1 (STEAP1).
Oosterheert W; Gros P
J Biol Chem; 2020 Jul; 295(28):9502-9512. PubMed ID: 32409586
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a single b-type heme, FAD, and metal binding sites in the transmembrane domain of six-transmembrane epithelial antigen of the prostate (STEAP) family proteins.
Kleven MD; Dlakić M; Lawrence CM
J Biol Chem; 2015 Sep; 290(37):22558-69. PubMed ID: 26205815
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic analyses of the significance of STEAP1 and STEAP2 in lung cancer.
Liu T; Niu X; Li Y; Xu Z; Chen J; Xu G
World J Surg Oncol; 2022 Mar; 20(1):96. PubMed ID: 35346237
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of stepwise electron transfer in six-transmembrane epithelial antigen of the prostate (STEAP) 1 and 2.
Chen K; Wang L; Shen J; Tsai AL; Zhou M; Wu G
Elife; 2023 Nov; 12():. PubMed ID: 37983176
[TBL] [Abstract][Full Text] [Related]
6. The STEAP protein family: versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions.
Grunewald TG; Bach H; Cossarizza A; Matsumoto I
Biol Cell; 2012 Nov; 104(11):641-57. PubMed ID: 22804687
[TBL] [Abstract][Full Text] [Related]
7. STEAP proteins: from structure to applications in cancer therapy.
Gomes IM; Maia CJ; Santos CR
Mol Cancer Res; 2012 May; 10(5):573-87. PubMed ID: 22522456
[TBL] [Abstract][Full Text] [Related]
8. Six-Transmembrane Epithelial Antigen of Prostate 1 (STEAP1) Has a Single b Heme and Is Capable of Reducing Metal Ion Complexes and Oxygen.
Kim K; Mitra S; Wu G; Berka V; Song J; Yu Y; Poget S; Wang DN; Tsai AL; Zhou M
Biochemistry; 2016 Dec; 55(48):6673-6684. PubMed ID: 27792302
[TBL] [Abstract][Full Text] [Related]
9. Six-transmembrane epithelial antigen of the prostate 1 is associated with tumor invasion and migration in endometrial carcinomas.
Sun J; Ji G; Xie J; Jiao Z; Zhang H; Chen J
J Cell Biochem; 2019 Jul; 120(7):11172-11189. PubMed ID: 30714206
[TBL] [Abstract][Full Text] [Related]
10. Targeting STEAP1 as an anticancer strategy.
Nakamura H; Arihara Y; Takada K
Front Oncol; 2023; 13():1285661. PubMed ID: 37909017
[TBL] [Abstract][Full Text] [Related]
11. STEAP1 is overexpressed in cancers: a promising therapeutic target.
Moreaux J; Kassambara A; Hose D; Klein B
Biochem Biophys Res Commun; 2012 Dec; 429(3-4):148-55. PubMed ID: 23142226
[TBL] [Abstract][Full Text] [Related]
12. Expression of STEAP1 and STEAP1B in prostate cell lines, and the putative regulation of STEAP1 by post-transcriptional and post-translational mechanisms.
Gomes IM; Santos CR; Maia CJ
Genes Cancer; 2014 Mar; 5(3-4):142-51. PubMed ID: 25053991
[TBL] [Abstract][Full Text] [Related]
13. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
[TBL] [Abstract][Full Text] [Related]
14. Six-transmembrane epithelial antigen of the prostate 1 accelerates cell proliferation by targeting c-Myc in liver cancer cells.
Iijima K; Nakamura H; Takada K; Hayasaka N; Kubo T; Umeyama Y; Iyama S; Miyanishi K; Kobune M; Kato J
Oncol Lett; 2021 Jul; 22(1):546. PubMed ID: 34335918
[TBL] [Abstract][Full Text] [Related]
15. Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.
Bhatia V; Kamat NV; Pariva TE; Wu LT; Tsao A; Sasaki K; Sun H; Javier G; Nutt S; Coleman I; Hitchcock L; Zhang A; Rudoy D; Gulati R; Patel RA; Roudier MP; True LD; Srivastava S; Morrissey CM; Haffner MC; Nelson PS; Priceman SJ; Ishihara J; Lee JK
Nat Commun; 2023 Apr; 14(1):2041. PubMed ID: 37041154
[TBL] [Abstract][Full Text] [Related]
16. The Tumor Suppressive Roles and Prognostic Values of STEAP Family Members in Breast Cancer.
Wu HT; Chen WJ; Xu Y; Shen JX; Chen WT; Liu J
Biomed Res Int; 2020; 2020():9578484. PubMed ID: 32802887
[TBL] [Abstract][Full Text] [Related]
17. Six-transmembrane epithelial antigen of the prostate 1 expression promotes ovarian cancer metastasis by aiding progression of epithelial-to-mesenchymal transition.
Jiao Z; Huang L; Sun J; Xie J; Wang T; Yin X; Zhang H; Chen J
Histochem Cell Biol; 2020 Aug; 154(2):215-230. PubMed ID: 32382787
[TBL] [Abstract][Full Text] [Related]
18. Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer.
Jin Y; Lorvik KB; Jin Y; Beck C; Sike A; Persiconi I; Kvaløy E; Saatcioglu F; Dunn C; Kyte JA
Mol Ther Oncolytics; 2022 Sep; 26():189-206. PubMed ID: 35860008
[TBL] [Abstract][Full Text] [Related]
19. STEAP1 protein overexpression is an independent marker for biochemical recurrence in prostate carcinoma.
Ihlaseh-Catalano SM; Drigo SA; de Jesus CM; Domingues MA; Trindade Filho JC; de Camargo JL; Rogatto SR
Histopathology; 2013 Nov; 63(5):678-85. PubMed ID: 24025158
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]